A5086730773- Cancer survivorship and care
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Cancer-related cognitive impairment studies
- Central Venous Catheters and Hemodialysis
- Lung Cancer Treatments and Mutations
- Music Therapy and Health
- Neuroscience and Music Perception
- Family Support in Illness
- Genetic factors in colorectal cancer
- Bladder and Urothelial Cancer Treatments
- COVID-19 and healthcare impacts
- Heart Rate Variability and Autonomic Control
- Empathy and Medical Education
- Cancer Treatment and Pharmacology
- Mental Health via Writing
- Cancer Immunotherapy and Biomarkers
- Chemotherapy-related skin toxicity
- Lung Cancer Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- COVID-19 and Mental Health
- Colorectal and Anal Carcinomas
- Parkinson's Disease and Spinal Disorders
- Ultrasound in Clinical Applications
- Dialysis and Renal Disease Management
Ospedaliera di Piacenza
2010-2021
Azienda Unità Sanitaria Locale Piacenza
2016-2017
Guglielmo da Saliceto Hospital
2005-2016
Policlinico S.Orsola-Malpighi
1995
A central venous catheter (CVC) currently represents the most frequently adopted intravenous line for patients undergoing infusional chemotherapy and/or high-dose with hematopoietic stem-cell transplantation and parenteral nutrition. CVC insertion a risk pneumothorax, nerve or arterial punctures. The aim of this prospective observational study was to explore safety efficacy under ultrasound (US) guidance confirm its utility in clinical practice cancer patients.Consecutive adult attending...
Background Cancer patients are presumed a frail group at high risk to contract coronavirus disease (COVID-19). The aim of this study was investigate the prevalence SARS-CoV-2 (severe acute respiratory syndrome 2) infection in asymptomatic cancer attending outpatient clinic general hospital region with (North Italy, first wave). Methods We retrospectively analyzed data consecutive oncology unit, General Hospital Piacenza. All having underlying cancer, without clinical suspicion COVID-19,...
4068 Background: Treatment options for advanced or metastatic gastric cancer (A/MGC) are limited and therefore inclusion of novel substances is necessary. Few studies have confirmed the activity tolerability combination oxaliplatin (OXA) 5-fluorouracil (5-FU) modulated with leucovorin (LV) administered to patients (pts) A/MGC. Methods: Thirty-five A/MGC treated FOLFOX-4 regimen. All had a pathologically at least one measurable lesion, 14 pts (40%) were previously untreated 21 (60%) received...
Metastatic/advanced colorectal cancer is considered a resistant disease and oncologic emergencies secondary to advanced may be regarded with nihilistic attitude. The objective of this report emphasize the efficacy oxaliplatin/5-fluorouracil/leucovorin regimen (FOLFOX-4) in three patients presenting colon cancer. first case was 40-year-old man severe respiratory insufficiency due massive carcinomatous lymphangitis; subsequently cecal adenocarcinoma diagnosed. patient's conditions became...
8152 Background: The management of the cancer patients frequently relies on ability to deliver a variety intravenous agents over prolonged period. A central venous catheter (CVC) currently represents most adopted line for undergoing infusional chemotherapy and/or high-dose with concomitant blood stem cell transplantation and parenteral nutrition. aim this study was explore feasibility safety CVC insertion under ultrasound (US) control. US offers advantage real-time, multiplanar imaging as...
e19582 Background: Thoracentesis is an essential procedure in attempt to delineate the etiology of fluid collection or relieve symptoms oncologic patients. One most common complication thoracentesis pneumothorax, which has been reported occur 2%-30% thoracenteses, with 15%-50% these patients requiring tube thoracostomy. Methods: To assess whether thoracenteses performed ultrasound (US) guidance are associated a lower rates pneumothorax and thoracostomy than those without US guidance, we...